SANDRA KINGSBURY: Open Payments
NPI 1134821036 · FORT WORTH, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$5,980 in 234 payments from 33 companies in 2025. Trend: 2023 $2,673 · 2024 $5,008 · 2025 $5,980
Food & beverage: $5,924Education: $56
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 30 | $1,176 |
| GlaxoSmithKline, LLC. | 38 | $634 |
| Verona Pharma, Inc. | 17 | $399 |
| Regeneron Healthcare Solutions, Inc. | 13 | $280 |
| Viatris Specialty LLC | 14 | $260 |
| Grifols USA, LLC | 7 | $258 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 6 | $245 |
| Baxter Healthcare | 15 | $208 |
| Amgen Inc. | 19 | $198 |
| Actelion Pharmaceuticals US, Inc. | 4 | $198 |
Products named: DUPIXENT, AIRSUPRA, Ohtuvayre, BREZTRI, NUCALA, TEZSPIRE, FASENRA, YUPELRI.
Industry payments across TX — which companies pay providers there.
